GlaxoSmithKline to cease providing corporate political contributions
- Details
- Category: GlaxoSmithKline

Glivec shows significant benefit for gastrointestinal stromal tumor (GIST) patients
- Details
- Category: Novartis

AstraZeneca and MAP Pharmaceuticals Announce Worldwide Collaboration
- Details
- Category: AstraZeneca

First and Only Fibrate Indicated for Use in Combination With a Statin for Cholesterol Management
- Details
- Category: Abbott

Bayer innovations provide solutions for the global challenges of the future
- Details
- Category: Bayer

Roche and Axiogenesis Enter into Co-Development and Marketing Agreement
- Details
- Category: Roche
Roche and Axiogenesis AG, Cologne, Germany have entered into an agreement for the development and distribution for Axiogenesis' Cor.At(R) 100% pure cardiomyocytes platform as an integral part of the xCELLigence life cell analysis system. Under the terms of the agreement, RAS will market cell-systems, based on the technology of Axiogenesis Cor.At being customize for the xCELLigence platform.
Pfizer and Sigma-Tau Announce an Agreement to Market a Potential New Treatment for Malaria
- Details
- Category: Pfizer

More Pharma News ...
- AstraZeneca and Bristol-Myers Squibb Announce Expansion of Worldwide Collaboration
- GSK analysis shows Seretide/Advair is a well tolerated and effective medicine
- Bayer Schering Pharma expands men's healthcare portfolio
- Children in the world's poorest countries to get free insulin
- Roche signs definitive agreement to acquire Memory Pharmaceuticals
- Pfizer's Novel HIV/AIDS Treatment SELZENTRY™
- AstraZeneca Settles US Pulmicort Respules Patent Litigation with Teva